International Flavors & Fragrances Inc. (BCBA:IFF)
Argentina · Delayed Price · Currency is ARS | Market Cap | 37.28T +59.6% |
| Revenue (ttm) | 15.97T +11.5% |
| Net Income | 410.38B |
| EPS | 139.33 |
| Shares Out | n/a |
| PE Ratio | 94.45 |
| Forward PE | 27.86 |
| Dividend | 142.66 (1.08%) |
| Ex-Dividend Date | Dec 18, 2026 |
| Volume | 155 |
| Open | 13,030 |
| Previous Close | 12,810 |
| Day's Range | 13,030 - 13,170 |
| 52-Week Range | 7,570 - 13,160 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 3, 2026 |
About BCBA:IFF
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and markets food, beverage, health and biosciences, scent, and complementary adjacent products in the United States, and internationally. It operates in through Taste, Food Ingredients, Health & Biosciences, and Scent segments. The Taste segment offers savory products such as soups, sauces, meat, fish, poultry, snacks; beverages consists of juice drinks, carbonated or flavored beverages, spirits; sweets comprising, bakery products, candy, cereal, chewing gum; ... [Read more]
News
IFF Declares Dividend for Fourth Quarter 2026
NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on January 13, ...
IFF Identifies Ten Consumer Moments Reshaping Food and Beverage Innovation in the GLP-1 Era
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF)—a global leader in flavors, fragrances and health and biosciences, today launched its latest report, “GLP-1 Consumer Moments of Opportunity.” The report unco...
IFF price target raised to $108 from $95 at Oppenheimer
Oppenheimer analyst Kristen Owen raised the firm’s price target on IFF (IFF) to $108 from $95 and keeps an Outperform rating on the shares. Fundamentals across the firm’s agricultural names…
IFF price target lowered to $95 from $101 at BofA
BofA analyst Matthew DeYoe lowered the firm’s price target on IFF (IFF) to $95 from $101 and keeps a Buy rating on the shares. The firm adjusted targets in the…
IFF price target raised to $105 from $96 at Barclays
Barclays raised the firm’s price target on IFF (IFF) to $105 from $96 and keeps an Overweight rating on the shares. The firm adjusted targets in the consumer staples group…
IFF to Release Third Quarter 2026 Results on November 3, 2026
NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) today announced that it will release its third quarter 2026 earnings results following the market close on Tuesday, November 3, 2026. The management...
IFF price target raised to $95 from $85 at Argus
Argus raised the firm’s price target on IFF (IFF) to $95 from $85 and keeps a Buy rating on the shares. The firm states that it has a favorable view…
IFF price target lowered to $100 from $101 at Citi
Citi lowered the firm’s price target on IFF (IFF) to $100 from $101 and keeps a Buy rating on the shares. The firm adjusted targets in the specialty chemicals group…
IFF publishes ‘Dear Dairy: The Life Stages Guide’
IFF (IFF) published its latest resource, Dear Dairy: The Life Stages Guide. This strategic guide reveals how manufacturers can unlock new opportunities by aligning dairy innovation with consumers’ evo...
IFF Identifies the Life-Stage Insights Shaping Dairy's Future
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF)—a global leader in flavors, fragrances and health and biosciences, published its latest resource, Dear Dairy: The Life Stages Guide. This strategic guide rev...
IFF Introduces AQUASCENT™: Advanced Water-Based Fragrance Technology
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF), a global leader in flavors, fragrances and health and biosciences, today introduced AQUASCENT™, a new vegan, water-based carrier for fine fragrance. Crafted...
IFF launches Omni-Bos PHY phytase enzyme
IFF (IFF) announced the launch of Omni-Bos PHY, a novel phytase enzyme designed specifically for dairy cattle. The technology helps producers improve nutrient utilization and feed efficiency by unlock...
IFF Launches Omni-Bos™ PHY to Help Dairy Producers Get More Value from Feed
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) — a global leader in flavors, fragrances and health and biosciences — today announced the launch of Omni-Bos™ PHY, a novel phytase enzyme designed specifical...
IFF initiated with a Sector Weight at KeyBanc
KeyBanc initiated coverage of IFF (IFF) with a Sector Weight rating and no price target The firm rolled out coverage on 19 chemical and agriculture companies, with nine Overweights, nine…
IFF initiated with a Sector Weight at KeyBanc
KeyBanc initiated coverage of IFF (IFF) with a Sector Weight rating.
International Flavors & Fragrances Transcript: Barclays 19th Annual Global Consumer Conference
The organization has transformed into three focused, innovation-driven businesses, improving financial health, talent retention, and operational discipline. Growth is driven by enhanced R&D, automation, and a balanced customer mix, with further gains expected as capacity investments and strategic divestitures are completed.
India investigates fragrance giants over price collusion, document shows
Global fragrance makers Givaudan , Firmenich and International Flavors & Fragrances face a second antitrust investigation by Indian authorities, according to a regulatory document seen by Reuters.
IFF Report Finds GLP-1 Is Reshaping Food Choices and Eating Behaviors Among Indian Consumers
NEW DELHI--(BUSINESS WIRE)--IFF (NYSE: IFF) — a global leader in flavors, fragrances and health and biosciences — released new research examining how GLP-1 use is influencing food behaviors among Indi...
IFF to Webcast Fireside Chat at Barclays Global Consumer Conference on Sept. 10
NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) today announced that Chief Executive Officer Erik Fyrwald will participate in a fireside chat at the Barclays Global Consumer Conference on Thursday...
IFF price target raised to $96 from $90 at Barclays
Barclays raised the firm’s price target on IFF (IFF) to $96 from $90 and keeps an Overweight rating on the shares. The company’s sales growth accelerated in Q2, and it…
IFF price target raised to $100 from $95 at Morgan Stanley
Morgan Stanley analyst Lisa De Neve raised the firm’s price target on IFF (IFF) to $100 from $95 and keeps an Overweight rating on the shares. IFF continues to screen…
IFF price target raised to $100 from $90 at Baird
Baird analyst Ghansham Panjabi raised the firm’s price target on IFF (IFF) to $100 from $90 and keeps an Outperform rating on the shares.
IFF price target raised to $91 from $84 at UBS
UBS analyst Joshua Spector raised the firm’s price target on IFF (IFF) to $91 from $84 and keeps a Neutral rating on the shares.
IFF downgraded to Hold from Buy at Vertical Research
Vertical Research downgraded IFF (IFF) to Hold from Buy with a $93 price target